Card image cap

Katie Porter's Public Statements on Issue: Drugs

Office:
Date Title
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/16/2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
04/14/2021 Reps. Porter, DeLauro Reintroduce Legislation to Protect Patients from Paying More for Drugs
04/06/2021 Letter to Secretary of Health and Human Services, Xavier Beccera - Trone, Kuster, Barragán, Porter Lead Letter to HHS Urging Extension and Expansion of Public Health Emergency from Opioid Crisis
09/25/2019 With Rep. Porter Support, House Passes Bipartisan Bill to Protect Financial Institutions that Service State-Legal Marijuana Businesses
08/19/2019 Letter to the Hon. William Barr, Attorney General of the U.S. Department of Justice - Representative Mike Levin Requests Information from DOJ on Enforcement of Patient Brokering Law
06/05/2019 Letter to the Hon. Robert Wilkie, Secretary of the Department of Veteran Affairs - Rep. Tulsi Gabbard: Protect VA Benefits for Veterans Employed in State-Legalized Cannabis Industry
03/29/2019 Rep. Porter-backed Bill to Protect Financial Institutions Serving Marijuana Businesses Clears Key Committee Hurdle
arrow_upward